Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-017861
Filing Date
2025-06-20
Accepted
2025-06-20 16:27:18
Documents
2
Period of Report
2025-06-18

Document Format Files

Seq Description Document Type Size
1 form3-06202025_080615.html 3  
1 form3-06202025_080615.xml 3 1667
2 ex24-06202025_080615.htm EX-24 6634
  Complete submission text file 0001415889-25-017861.txt   9826
Mailing Address C/O OXIGENE, INC. 230 THIRD AVENUE WALTHAM MA 02451
Business Address
Chin Richard (Reporting) CIK: 0001337252 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40632 | Film No.: 251061776

Mailing Address 47215 LAKEVIEW BOULEVARD FREMONT CA 94538
Business Address 47215 LAKEVIEW BOULEVARD FREMONT CA 94538 (877) 922-9835
Cytek Biosciences, Inc. (Issuer) CIK: 0001831915 (see all company filings)

EIN.: 472547526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)